loadpatents
Patent applications and USPTO patent grants for Mangukiya; Hitesh Bhagavanbhai.The latest application filed is for "formulation of nanoantibody based drugs and a method for treating thrombotic thrombocytopenic purpura by inhalation".
Patent | Date |
---|---|
Formulation of tocilizumab and method for treating COVID-19 by inhalation Grant 11,365,248 - Huang , et al. June 21, 2 | 2022-06-21 |
Formulation Of Nanoantibody Based Drugs And A Method For Treating Thrombotic Thrombocytopenic Purpura By Inhalation App 20220064328 - Huang; Cai Gu ;   et al. | 2022-03-03 |
Biopharmaceutical Formulation Of Anti-pd-1, Anti-pd-l1, And Anti-vegfr Therapeutic Monoclonal Antibodies And Method For Treating Nsclc By Inhalation App 20210403568 - Huang; Cai Gu ;   et al. | 2021-12-30 |
Formulation Of Tocilizumab And Method For Treating Covid-19 By Inhalation App 20210403550 - Huang; Cai Gu ;   et al. | 2021-12-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.